Heart DiseaseIntroForumsNewsAnatomy & PhysiologyLaboratory
Search

Heart DiseaseIntroForumsNewsAnatomy & PhysiologyHeartzineFish Oil Capsules Cut Death Risk for Heart PatientsKids with Fatty Liver Face Increased Heart RiskLow Fat Milk Can Cut Heart Disease RiskMarijuana Ups Heart Attack, Stroke RiskLaboratory Letters to the Editor
 
 

In the Forum

Anti-clotting Drugs Present Big Risk

      Volume: 12 (10/09/2005)
Giving patients a clot-busting drug before planned angioplasty, a common practice nowadays, has been recently found to be dangerous.

Clot dissolvers are usually given to patients a few hours before angioplasty in the hope that it will make the operation more successful. However, the recent research led by Dr. Frans Van de Werf of the Catholic University of Leuven in Belgium has proved that more patients who were given the drug died within the following month after angioplasty than patients who were not. The findings were presented at the annual conference of the European Society of Cardiology in Stockholm, Sweden.

ADVERTISEMENT

Angioplasty is one of the options available for treating heart attack victims, apart from clot dissolver treatment. It is considered a very effective option, when performed by experienced doctors in well-equipped hospitals. Angioplasty implies threading a wire through the blood vessels to mechanically break up the clot that caused the heart attack. A balloon is inflated to squash plaque against the walls of the artery, and then a tiny mesh tube is implanted at the site of a blockage, to keep the artery open permanently.

When a hospital does not have the necessary expertise to perform such an operation, patients are either treated with a clot-dissolving drug or transferred to another hospital, to have the angioplasty performed within the next 3 hours. It is not clear, however, if the use of a clot-buster is beneficial in cases where angioplasty can be performed, but only within 1-3 hours after the heart attack.

The current study compared strategies among 1,667 patients in various hospitals, half of which were given a clot-buster before angioplasty; the other half were administered a fake pill.

6% of the patients who received the drug (TNKase) died within the next month following the angioplasty, as compared to only 3.8%, in the group who took fake pills. The study was stopped prematurely, immediately after this big difference in death rates became clear.

Related Discussions

I want to present You!
Anti-Depressantz
anti spyware

Related Articles

Anti-inflammatory Effects of Fish Reduce Risk of Heart Disease
Heart at Serious Risk from Diabetes Drugs
Repeat Heart Attack Risk with COX-2 Drugs
Signup to the Newsletter
 
Enter your email:
Download as PDF
 
PDF Version
For Printing or Archiving
Add to Bookmarks
 
Add Bookmark

ADVERTISEMENT



 Copyright © Alloyfish Ltd. 2005-6. This site does not provide any medical advice. Do not make medical decisions without a doctor.